<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2306-4102</journal-id>
<journal-title><![CDATA[Acta ortopédica mexicana]]></journal-title>
<abbrev-journal-title><![CDATA[Acta ortop. mex]]></abbrev-journal-title>
<issn>2306-4102</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Ortopedia y Traumatología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2306-41022017000400177</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[A comparative study in patients with fractures of the lower limbs between rivaroxaban versus enoxaparin and its impact on bone healing time]]></article-title>
<article-title xml:lang="es"><![CDATA[Estudio comparativo en pacientes con fracturas de extremidades inferiores entre rivaroxaban versus enoxaparina como terapia profiláctica antitrombótica y su impacto en el tiempo de consolidación]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peláez-Damy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres-Gómez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mas-Celis]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Villalobos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico ABC  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro Médico ABC  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Centro Médico ABC Hospital Shriners ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>4</numero>
<fpage>177</fpage>
<lpage>181</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2306-41022017000400177&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2306-41022017000400177&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2306-41022017000400177&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Background:  Each year it is estimated in the United States an approximate of 8 million fractures; 5 to 10% develop delayed union or absence of periosteal new bone. There are several factors that can cause delay in fracture healing, among the well known, is the use of prophylactic antithrombotic therapy for deep vein thrombosis (DVT). DVT appears in 40 to 60% of the patients undergoing orthopedic surgery without prophylactic antithrombotic therapy. The goal of this study was to assess whether there is a difference in time of bone healing in lower limb fractures (femur and tibia) comparing rivaroxaban to enoxaparin as the prophylactic antithrombotic management.  Material and methods:  We present a retrospective observational and analytic study in a sample of cases. It is a cross-sectional study with patient data from the database of the American British Cowdray (ABC) Medical Center. We included patients with femur and tibia fractures under antithrombotic prophylactic management with rivaroxaban or enoxaparin during the period of January 2011 to December 2012. Our sample included 32 patients separated into two groups. Student&#8217;s t-test was used for comparing parametric variables and the Mann-Whitney U test for nonparametric variables. Linear regression model was preformed considering the variables related to the time it took the fracture to heal.  Results:  All fractures consolidated in a time of 13 and 14 weeks for rivaroxaban and enoxaparin respectively (p = 0.67).  Discussion:  We found no difference in bone healing time for lower limb fractures in patients receiving antithrombotic prophylaxis treatment comparing rivaroxaban with enoxaparin.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Antecedentes:  En Estados Unidos se presentan aproximadamente ocho millones de fracturas anuales y de ellas entre cinco y 10% desarrollan retraso o ausencia en la consolidación ósea. Existen diferentes factores bien conocidos que promueven este retraso, entre los cuales se encuentra el uso de los antitrombóticos como terapia profiláctica de la trombosis venosa profunda, la cual aparece de 40 a 60% en pacientes que no los utilizan y son sometidos a cirugías ortopédicas. El objetivo de este estudio fue evaluar si existe diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes sometidos a terapia profiláctica antitrombótica comparando rivaroxabán con enoxaparina.  Material y métodos:  Presentamos un estudio descriptivo y analítico con muestreo a conveniencia de casos retrospectivos. Es un estudio transversal con datos recolectivos. Se revisó la base de datos del Centro Médico ABC y se incluyeron pacientes con diagnóstico de fracturas de fémur y tibia sometidos a manejo profiláctico antitrombótico con rivaroxabán o enoxaparina durante el periodo de Enero 2011 a Diciembre de 2012. La muestra total se constituyó de 32 pacientes divididos en dos grupos. Se utilizó la prueba T de Student para comparar variables paramétricas y la prueba U de Mann-Whitney para las no-paramétricas. Se realizó un modelo de regresión lineal considerando las variables relacionadas con el tiempo de consolidación ósea.  Resultados:  Todas las fracturas consolidaron, presentando un tiempo de 13 semanas con rivaroxabán y de 14 semanas (p = 0.67) con enoxaparina.  Discusión:  No encontramos diferencia en el tiempo de consolidación de las fracturas de los huesos de las extremidades pélvicas (fémur y tibia) en pacientes que reciben antitrombóticos como profilaxis comparando rivaroxabán con enoxaparina.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Femur fractures]]></kwd>
<kwd lng="en"><![CDATA[tibia fractures]]></kwd>
<kwd lng="en"><![CDATA[bone healing]]></kwd>
<kwd lng="en"><![CDATA[antithrombotic prophylaxis]]></kwd>
<kwd lng="en"><![CDATA[rivaroxaban]]></kwd>
<kwd lng="en"><![CDATA[enoxaparin]]></kwd>
<kwd lng="es"><![CDATA[fracturas de fémur]]></kwd>
<kwd lng="es"><![CDATA[fracturas de tibia]]></kwd>
<kwd lng="es"><![CDATA[consolidación ósea]]></kwd>
<kwd lng="es"><![CDATA[antitrombóticos]]></kwd>
<kwd lng="es"><![CDATA[rivaroxabán]]></kwd>
<kwd lng="es"><![CDATA[enoxaparina]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Brighton]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Ryaby]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nielson]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Lorich]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilización de fuerzas físicas en la consolidación ósea]]></article-title>
<source><![CDATA[J Am Acad Orthop Surg (Ed Esp)]]></source>
<year>2003</year>
<volume>2</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>388-98</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colchero]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La consolidación de las fracturas, su fisiología y otros datos clínicos de importancia]]></article-title>
<source><![CDATA[Revista Médica IMSS]]></source>
<year>1982</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>374-81</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Achenbach]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Khosla]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Melton]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in fracture incidence a population-bases study over 20 years]]></article-title>
<source><![CDATA[J Bone Miner Res]]></source>
<year>2014</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>581-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores clínicos que modifican la consolidación de fracturas]]></article-title>
<source><![CDATA[Avances en Traumatología, Cirugía Ortopédica y Rehabilitación]]></source>
<year>2005</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>153-62</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pretell]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastornos de la consolidación retardo y pseudoartrosis]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2009</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Babhulkar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pande]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Babhulkar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nonunion of the diaphysis of long bones]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2005</year>
<numero>431</numero>
<issue>431</issue>
<page-range>50-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Alcántara]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Agentes sistémicos que modifican la consolidación de las fracturas]]></article-title>
<source><![CDATA[Rev Esp Ortop Traumatol]]></source>
<year>2006</year>
<volume>50</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5-12</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giannoudis]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Matthws]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Furlong]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[De Boer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nonunion of the femoral diaphysis The influence of reaming and non-steroidal anti-inflammatory drugs]]></article-title>
<source><![CDATA[J Bone Joint Surg]]></source>
<year>2000</year>
<volume>82</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>655-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Biermann]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Doughetry]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The musculoskeletal effects of cigarette smoking]]></article-title>
<source><![CDATA[J Bone Joint Surg Am]]></source>
<year>2013</year>
<volume>95</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>850-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Street]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[McGrath]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[O'Regan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wakai]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[McGuinness]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Redmond]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thromboprophylaxis using a low molecular weight heparin delays fracture repair]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>2000</year>
<numero>381</numero>
<issue>381</issue>
<page-range>278-89</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seung]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Chin]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Kyoung]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Soon-Sun]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of deep vein thrombosis after major lower limb orthopedic surgery analysis of a nationwide claim registry]]></article-title>
<source><![CDATA[Yonsei Med J]]></source>
<year>2015</year>
<volume>56</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>139-45</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turpie]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis]]></article-title>
<source><![CDATA[Am J Surg]]></source>
<year>1991</year>
<volume>161</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>532-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Fleet]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Mcarthur]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gard]]></surname>
<given-names><![CDATA[AX]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rivaroxaban vs low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2014</year>
<volume>12</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1626-35</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rajgopal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bear]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Butcher]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Shaughnessy]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of heparin and low molecular weight heparins on bone]]></article-title>
<source><![CDATA[Thromb Res]]></source>
<year>2008</year>
<volume>122</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>293-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>European Commission approval for Xarelto. European Medicines Agency</collab>
<source><![CDATA[Evaluation of Medicines for Human Use]]></source>
<year>2008</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eriksson]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
<name>
<surname><![CDATA[Kakkar]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Turpie]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Gent]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bandel]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Homering]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement]]></article-title>
<source><![CDATA[J Bone Joint Surg Br]]></source>
<year>2009</year>
<volume>91</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>636-44</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walenga]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Bick]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy]]></article-title>
<source><![CDATA[Med Clin North Am]]></source>
<year>1998</year>
<volume>82</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>635-58</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gigi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salai]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dolkart]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Chechik]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Katzburg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Stern]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Somjen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of direct factor Xa inhibitor (rivaroxaban) on the human osteoblastic cell line SaOS2]]></article-title>
<source><![CDATA[Connect Tissue Res]]></source>
<year>2012</year>
<volume>53</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>446-50</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Somjen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Katzburg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gigi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dolkart]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Sharon]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Salai]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal-induced physiological modulations in human females osteoblastic cell line SaSO2]]></article-title>
<source><![CDATA[J Steroid Biochem Mol Biol]]></source>
<year>2013</year>
<numero>135</numero>
<issue>135</issue>
<page-range>67-70</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Solayar]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Mulhall]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of a new direct Factor Xa inhibitor on human osteoblasts an in vitro study comparing the effect of rivaroxaban with enoxaparin]]></article-title>
<source><![CDATA[BMC Musculoskeletal Disordr]]></source>
<year>2011</year>
<volume>12</volume>
<page-range>247</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyna]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Regalado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aplicación de medulla ósea autologa en retardos de consolidación y seudoartrosis postraumática]]></article-title>
<source><![CDATA[Acta Ortopédica Mexicana]]></source>
<year>2005</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>248-51</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
